LFSC vs. XLV
LFSC (F/m Emerald Life Sciences Innovation ETF) and XLV (State Street Health Care Select Sector SPDR ETF) are both Health & Biotech Equities funds. LFSC is actively managed, while XLV is passively managed. Over the past year, LFSC returned 75.19% vs 15.69% for XLV. At a 0.48 correlation, their price movements are largely independent. LFSC charges 0.54%/yr vs 0.08%/yr for XLV.
Performance
LFSC vs. XLV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LFSC achieves a 15.76% return, which is significantly higher than XLV's -2.23% return.
LFSC
- 1D
- 2.09%
- 1M
- 10.64%
- YTD
- 15.76%
- 6M
- 8.23%
- 1Y
- 75.19%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XLV
- 1D
- 0.88%
- 1M
- 0.56%
- YTD
- -2.23%
- 6M
- -2.55%
- 1Y
- 15.69%
- 3Y*
- 6.13%
- 5Y*
- 5.50%
- 10Y*
- 9.86%
LFSC vs. XLV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
LFSC F/m Emerald Life Sciences Innovation ETF | 15.76% | 56.54% | -6.51% |
XLV State Street Health Care Select Sector SPDR ETF | -2.23% | 14.50% | -6.70% |
Correlation
The correlation between LFSC and XLV is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.44 |
Correlation (All Time) Calculated using the full available price history since Oct 31, 2024 | 0.48 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LFSC vs. XLV — Risk / Return Rank
LFSC
XLV
LFSC vs. XLV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for F/m Emerald Life Sciences Innovation ETF (LFSC) and State Street Health Care Select Sector SPDR ETF (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LFSC | XLV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.80 | ||
| Sortino ratioReturn per unit of downside risk | +2.11 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.19 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | 4.65 | 1.51 | +3.15 |
| Martin ratioReturn relative to average drawdown | 12.98 | 3.56 | +9.42 |
Loading charts...
Drawdowns
LFSC vs. XLV - Drawdown Comparison
The maximum LFSC drawdown since its inception was -29.74%, smaller than the maximum XLV drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for LFSC and XLV.
Loading charts...
Drawdown Indicators
| LFSC | XLV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -29.74% | -39.17% | +9.43% |
Max Drawdown (1Y)Largest decline over 1 year | -16.25% | -10.47% | -5.78% |
Max Drawdown (3Y)Largest decline over 3 years | — | -17.11% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -17.11% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.40% | — |
Current DrawdownCurrent decline from peak | 0.00% | -5.53% | +5.53% |
Average DrawdownAverage peak-to-trough decline | -7.60% | -7.12% | -0.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.81% | 4.42% | +1.39% |
Volatility
LFSC vs. XLV - Volatility Comparison
F/m Emerald Life Sciences Innovation ETF (LFSC) has a higher volatility of 7.93% compared to State Street Health Care Select Sector SPDR ETF (XLV) at 5.14%. This indicates that LFSC's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LFSC | XLV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.93% | 5.14% | +2.79% |
Volatility (6M)Calculated over the trailing 6-month period | 18.96% | 10.58% | +8.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.61% | 15.06% | +11.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.93% | 14.76% | +14.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.93% | 16.59% | +12.34% |
LFSC vs. XLV - Expense Ratio Comparison
LFSC has a 0.54% expense ratio, which is higher than XLV's 0.08% expense ratio.
Dividends
LFSC vs. XLV - Dividend Comparison
LFSC has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 2.11%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LFSC F/m Emerald Life Sciences Innovation ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XLV State Street Health Care Select Sector SPDR ETF | 2.11% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
LFSC and XLV have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LFSC has higher volatility (7.93%) compared to XLV (5.14%). In terms of maximum drawdown, LFSC dropped -29.74% vs XLV's -39.17%.
On 1-year performance, LFSC leads with 75.19% vs 15.69% for XLV. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 5.14%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, LFSC has performed better with a 75.19% return vs 15.69%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLV is cheaper with a 0.08% expense ratio, compared with 0.54% for LFSC.
XLV has the higher dividend yield at 2.11%, compared with 0.00% for LFSC.
They also come from different issuers: F/m Investments and State Street. Their fees differ too: 0.54% for LFSC and 0.08% for XLV.
LFSC currently has the higher Sharpe Ratio (2.85 vs 1.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LFSC and XLV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer